Cart
×
Learn more about REGENXBIO’s new gene therapy program for the potential treatment of Duchenne. This webinar provides an overview of the company and RGX-202, a novel, advanced micro-dystrophin gene therapy for the treatment of DMD.
You’ll be prompted to enter your name and email address to view the recording.